This controlled clinical trial will be part of a larger, 'virtual hospital-at-home'
(vHaH) project called Influenz-er. vHaH is a care model designed to deliver medical care
at home, as a substitute for a continued conventional inpatient hospital admission.

The overall aim of Influenz-er is to develop, implement and evaluate a novel Hospital at
Home model, that will enable safe and satisfactory admission of hospitalised patients
including epidemic patients in their homes.

Early Discharge - Evaluating a Virtual Hospital at Home Model

Epidemic Disease

Infections

Various versions of hospital-at-home models have been implemented as an emergency
solution to a steep increase in number of hospitalisations during the COVID-19 pandemic
crisis. Conventionally, epidemic patients who require medical monitoring, will be
admitted to the hospital. Recently, patients hospitalised for COVID-19 requiring medical
supervision for an extended period - sometimes for weeks - have been admitted to their
own home supported by telemedicine and/or mobile hospital-based care team (MHCT). Various
models of home-based admissions of pandemic patients have been implemented
internationally with great results regarding safety and effectiveness. These models are
mostly based on physical attendance of physicians in the patient's home and in most
situations implemented out of need. Home-based models provide promising results regarding
costs, but results are based on low-quality evidence. Health systems facing capacity
constraints and rising costs needs to allocate resources based on high-quality evidence.

Therefore, further research regarding feasibility, safety, satisfaction, costs, and
effectiveness of a vHaH model still needs to be done.

Danish hospital capacity will not allow for HaH models primarily depending on physical
attendance of physicians in the patient's home, nor will it be possible to manually
monitor all patient reported data. Therefore, there is a need for a telemedicine
supported vHaH model with a smart algorithm alarming clinical staff and thereby aiding in
timely handling of patient data and clinical state.

Project Influenz-er proposes an option of transfer to telemedicine supported vHaH model
as an alternative to continued standard hospital admission for the future. Patient safety
is a top priority regarding both the utilised technology and the re-organisation of
standard clinical responsibilities and tasks. Therefore, project Influenz-er included
several steps prior to the effectiveness evaluation in this clinical trial.

In the present study, knowledge from previous studies under project Influenz-er is
applied, and the vHaH is now ready to be evaluated in an effectiveness trial.

virtual Hospital at Home (vHaH)

Early Discharge - a Randomised Controlled Trial Evaluating Mental and Physical Effects on Acutely and Chronically Ill Patients in a Telemedicine Supported Virtual Hospital at Home Model

Daily step count and time in different activity levels will be measured using an
accelerometer placed on the thigh of the participant.

Evaluation through semi-structured interviews

Data will be extracted from patient-monitoring platform "mit e-hospital" and patient
record data

Data will be extracted from patient record data

Economic endpoint, evaluated using questionnaire EQ-5D-5L (EuroQol, 5 dimensions, 5
levels questionnaire).

On a scale 1 to 5, a score of 1 indicates the best health state, and higher scores
indicate more severe or frequent problems. In addition, there is a visual analogue scale
(VAS) to indicate the general health status with 100 indicating the best health status.

Participants are transferred home for telemedicine supported home-based admission.

Participants will follow a conventional hospital admission.

Early Discharge - Evaluating a Virtual Hospital at Home Model

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?

Locations

Location

Status